Improving the measurement properties of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): deriving a valid measurement total for the calculation of change

References

• Su WM, Cheng YF, Jiang Z, Duan QQ, Yang TM, Shang HF, et al. Predictors of survival in patients with amyotrophic lateral sclerosis: A large meta-analysis. EBioMedicine 2021;74:103732.
   PubMed Web of Science ®Google Scholar
• Wong C, Stavrou M, Elliott E, Gregory JM, Leigh N, Pinto AA, et al. Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective. Brain Commun. 2021;3:fcab242.
   PubMedGoogle Scholar
• Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13–21.
   PubMed Web of Science ®Google Scholar
• Franchignoni F, Mora G, Giordano A, Volanti P, Chiò A. Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Rasch analysis. J Neurol Neurosurg Psychiatry. 2013;84:1340–5.
   PubMed Web of Science ®Google Scholar
• Franchignoni F, Mandrioli J, Giordano A, Ferro S, ERRALS Group A further Rasch study confirms that ALSFRS-R does not conform to fundamental measurement requirements. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:331–7.
   PubMed Web of Science ®Google Scholar
• Bacci ED, Staniewska D, Coyne KS, Boyer S, White LA, Zach N, Pooled Resource Open-Access ALS Clinical Trials Consortium, et al. Item response theory analysis of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised in the Pooled Resource Open-Access ALS Clinical Trials Database. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:157–67.,.
   PubMed Web of Science ®Google Scholar
• Bakker LA, Schröder CD, van Es MA, Westers P, Visser-Meily JMA, van den Berg LH. Assessment of the factorial validity and reliability of the ALSFRS-R: a revision of its measurement model. J Neurol. 2017;264:1413–20.
   PubMed Web of Science ®Google Scholar
• van Eijk RPA, de Jongh AD, Nikolakopoulos S, McDermott CJ, Eijkemans MJC, Roes KCB, et al. An old friend who has overstayed their welcome: the ALSFRS-R total score as primary endpoint for ALS clinical trials. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22:300–7.
   PubMed Web of Science ®Google Scholar
• Forrest M, Andersen B. Ordinal scale and statistics in medical research. Br Med J (Clin Res Ed). 1986;292:537–8.
   PubMed Web of Science ®Google Scholar
• Wright BD, Linacre JM. Observations are always ordinal; measurements, however, must be interval. Arch Phys Med Rehabil. 1989;70:857–60.
   PubMed Web of Science ®Google Scholar
• Merbitz C, Morris J, Grip JC. Ordinal scales and foundations of misinference. Arch Phys Med Rehabil. 1989;70:308–12.
   PubMed Web of Science ®Google Scholar
• Stucki G, Daltroy L, Katz JN, Johannesson M, Liang MH. Interpretation of change scores in ordinal clinical scales and health status measures: the whole may not equal the sum of the parts. J Clin Epidemiol. 1996;49:711–7.
   PubMed Web of Science ®Google Scholar
• Rasch G. Probabilistic models for some intelligence and attainment tests. Chicago: University of Chicago Press; 1960.
   Google Scholar
• Andrich D. Components of variance of scales with a bifactor subscale structure from two calculations of alpha. Educ Measure. 2016;35:25–30.
   Google Scholar
• Young CA, Ealing J, McDermott CJ, Williams TL, Al-Chalabi A, Majeed T, et al. Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months. Amyotroph Lateral Scler Frontotemporal Degener. 2022; 24:82–90.
   PubMed Web of Science ®Google Scholar
• Gibbons CJ, Mills RJ, Thornton EW, Ealing J, Mitchell JD, Shaw PJ, et al. Rasch analysis of the hospital anxiety and depression scale (HADS) for use in motor neurone disease. Health Qual Life Outcomes. 2011;9:82–90.
   PubMed Web of Science ®Google Scholar
• EuroQol Research Foundation. EQ-5D-5L User Guide, 2019.
   Google Scholar
• Montes J, Levy G, Albert S, Kaufmann P, Buchsbaum R, Gordon PH, et al. Development and evaluation of a self-administered version of the ALSFRS-R. Neurology 2006;67:1294–6.
   PubMed Web of Science ®Google Scholar
• Balendra R, Jones A, Jivraj N, Knights C, Ellis CM, Burman R, et al. Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:279–84.
   PubMed Web of Science ®Google Scholar
• Reise SP, Moore TM, Haviland MG. Bifactor models and rotations: exploring the extent to which multidimensional data yield univocal scale scores. J Pers Assess. 2010;92:544–59.
   PubMed Web of Science ®Google Scholar
• Reise SP, Morizot J, Hays RD. The role of the bifactor model in resolving dimensionality issues in health outcomes measures. Qual Life Res. 2007;16(Suppl 1): 19–31.
   PubMed Web of Science ®Google Scholar
• Andrich D, Sheridan B, Luo G. RUMM2030: an MS Windows computer program for the analysis of data according to Rasch unidimensional models for measurement. Perth, Western Australia: RUMM Laboratory; 2015.
   Google Scholar
• Mokken RJ. A theory and procedure of scale analysis with applications in political research. Berlin, New York: De Gruyter Mouton; 1971.
   Google Scholar
• Doganay Erdogan B, Leung YY, Pohl C, Tennant A, Conaghan PG. Minimal clinically important difference as applied in rheumatology: an OMERACT Rasch working group systematic review and critique. J Rheumatol. 2016;43:194–202.
   PubMed Web of Science ®Google Scholar
• Ørnbjerg LM, Christensen KB, Tennant A, Hetland ML. Validation and assessment of minimally clinically important difference of the unadjusted Health Assessment Questionnaire in a Danish cohort: uncovering ordinal bias. Scand J Rheumatol. 2020;49:1–7.
   PubMed Web of Science ®Google Scholar
• Grimby G, Tennant A, Tesio L. The use of raw scores from ordinal scales: time to end malpractice? J Rehabil Med. 2012;44:97–8.
   PubMed Web of Science ®Google Scholar
• Mandrioli J, Biguzzi S, Guidi C, Sette E, Terlizzi E, Ravasio A, et al. Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy. Neurol Sci. 2015;36:2243–52.
   PubMed Web of Science ®Google Scholar
• Thakore NJ, Lapin BR, Pioro EP. Trajectories of impairment in amyotrophic lateral sclerosis: Insights from the Pooled Resource Open-Access ALS Clinical Trials cohort. Muscle Nerve. 2018;57:937–45.
   PubMed Web of Science ®Google Scholar
• van Eijk RPA, Nikolakopoulos S, Roes KCB, Kendall L, Han SS, Lavrov A, et al. Innovating clinical trials for amyotrophic lateral sclerosis: challenging the established order. Neurology 2021;97:528–36.
   PubMed Web of Science ®Google Scholar
• Ustün TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, et al. Developing the world health organization disability assessment schedule 2.0. Bull World Health Organ. 2010;88:815–23.
   PubMed Web of Science ®Google Scholar
• Young CA, Ealing J, McDermott CJ, Williams TL, Al-Chalabi A, Majeed T, et al. Measuring disability in amyotrophic lateral sclerosis/motor neuron disease: the WHODAS 2.0-36, WHODAS 2.0-32, and WHODAS 2.0-12. Amyotroph Lateral Scler Frontotemporal Degener. 2022;24:63–70.
   PubMed Web of Science ®Google Scholar
• Fournier CN, Bedlack R, Quinn C, Russell J, Beckwith D, Kaminski KH, et al. Development and validation of the Rasch-built overall amyotrophic lateral sclerosis disability scale (ROADS). JAMA Neurol. 2020;77:480–8.
   PubMed Web of Science ®Google Scholar
• Prodinger B, Coenen M, Hammond A, Küçükdeveci AA, Tennant A. Scale banking for patient-reported outcome measures that measure functioning in rheumatoid arthritis: a daily activities metric. Arthritis Care Res (Hoboken). 2022;74:579–87.
   PubMed Web of Science ®Google Scholar
• Fellinghauer CS, Prodinger B, Tennant A. The impact of missing values and single imputation upon Rasch analysis outcomes: a simulation study. J Appl Meas. 2018;19:1–25.
   PubMedGoogle Scholar
• Prell T, Gaur N, Steinbach R, Witte OW, Grosskreutz J. Modelling disease course in amyotrophic lateral Sclerosis: pseudo-longitudinal insights from cross-sectional health-related quality of life data. Health Qual Life Outcomes. 2020;18:117.
   PubMed Web of Science ®Google Scholar